APPLIED DNA SCIENCES INC's ticker is and the CUSIP is 03815U300. A total of 22 filers reported holding APPLIED DNA SCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171,259 | +2.6% | 139,187 | +7.6% | 0.00% | – |
| Q2 2023 | $166,867 | +14.2% | 129,355 | 0.0% | 0.00% | – |
| Q1 2023 | $146,171 | +68204.2% | 129,355 | 0.0% | 0.00% | – |
| Q4 2022 | $214 | -99.8% | 129,355 | +28.8% | 0.00% | – |
| Q3 2022 | $113,000 | +189.7% | 100,458 | +88.2% | 0.00% | – |
| Q2 2022 | $39,000 | -65.8% | 53,373 | 0.0% | 0.00% | – |
| Q1 2022 | $114,000 | -46.7% | 53,373 | 0.0% | 0.00% | – |
| Q4 2021 | $214,000 | -25.4% | 53,373 | 0.0% | 0.00% | – |
| Q3 2021 | $287,000 | +5.5% | 53,373 | +33.0% | 0.00% | – |
| Q2 2021 | $272,000 | +36.7% | 40,116 | +44.3% | 0.00% | – |
| Q1 2021 | $199,000 | +42.1% | 27,808 | +1.1% | 0.00% | – |
| Q4 2020 | $140,000 | -34.0% | 27,502 | 0.0% | 0.00% | – |
| Q3 2020 | $212,000 | +15.2% | 27,502 | +20.3% | 0.00% | – |
| Q2 2020 | $184,000 | +114.0% | 22,854 | +6.5% | 0.00% | – |
| Q1 2020 | $86,000 | -51.7% | 21,460 | -50.0% | 0.00% | – |
| Q4 2019 | $178,000 | – | 42,920 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 587,232 | $710,551 | 0.78% |
| AWM Investment Company, Inc. | 808,805 | $994,830 | 0.15% |
| SABBY MANAGEMENT, LLC | 38,900 | $47,069 | 0.03% |
| Moisand Fitzgerald Tamayo, LLC | 2,000 | $2,420 | 0.00% |
| Atria Wealth Solutions, Inc. | 81,010 | $98,022 | 0.00% |
| PROVENCE WEALTH MANAGEMENT GROUP | 2,000 | $2,420 | 0.00% |
| VANGUARD GROUP INC | 523,691 | $633,666 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 49,879 | $60,354 | 0.00% |
| UBS Group AG | 803 | $972 | 0.00% |
| OSAIC HOLDINGS, INC. | 1 | $1 | 0.00% |